1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
2Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact[J]. J Clin Virol, 2005, 32(2): 102-112.
3Arauz RP, Norder H, Robertson BH, et al. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America [J]. J Gen Virol, 2002, 83(Pt 8): 2059-2073.
4Li D, Gu HX, Zhang SY, et al. YMDD mutations and genotypes of hepatitis B virus in northern China [J]. Jpn J Infect Dis, 2006, 59(1): 42-45.
5Moskovitz DN, Osiowy C, Giles E, et al. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance [J]. J Viral Hepat, 2005, 12(4): 398-404.
6Yuen MF, Yuan HJ, Sablon E, et al. Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares [J]. J Clin Microbiol, 2004, 42(9): 3932-3936.
7Pan XP, Li LJ, Du WB, et al. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C[J]. J Viral Hepat, 2007, 14(11): 767-774.
8Svicher V, Gori C, Trignetti M, et al. The profile of mutational clusters associated with lamivudine resistance can be constrained by FIBV genotypes[J]. J Hepatol, 2009, 50(3): 461-470.
9Zollner B, Petersen J, Puchhammer SE, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D [J]. Hepatology, 2004, 39(1): 42-50.
10Kobayashi M, Suzuki F, Akuta N, et al. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C [J]. Journal of Medical Virology, 2006, 78(10): 1276-1283.
